TOP STORY Meibohm President-Elect of American College of Clinical Pharmacology Bernd Meibohm, PhD, professor of Pharmaceutical Sciences and associate dean for Research and Graduate Programs has been elected as 2012-14 president-elect of the American College of Clinical Pharmacology (ACCP). His term will begin during the ACCP Annual Meeting September 23-25, 2012 in San Diego. The president- elect is part of the executive committee and assumes the duties of the president in their absence. The president- elect succeeds the president once their two year term is complete. “Regarding the election, I am of course honored by the trust and confidence that the ACCP Board of Regents has put in me by electing me to this leadership role for the organization,” said Meibohm. “The American College of Clinical Pharmacology is truly an interprofessional organization in which pharmacists, physicians and scientists are working jointly together to improve drug development and applied pharmacotherapy. It overcomes the usual silo structure of other professional organizations and facilitates interactions among professionals as we all experience them in our daily work and practice.” September 2012 To serve as a model for pharmacy education, practice, research, and outreach in Tennessee and beyond UPCOMING EVENTS FEURT SYMPOSIUM Wednesday, September 19 18 th ANNUAL EMMETT MANLEY “PARSCRIPTION” GOLF TOURNAMENT Wednesday, September 19 Mirimichi Golf Course, Millington For information contact: [email protected]or [email protected]PHARMACY GRAND ROUNDS Thursday, September 20 Memphis COP Room 101, 12-1 pm CT Knoxville COP Room 220, 1-2 pm ET Drs. Rebecca Chhim and Andrea Franks K-TOWN THROWDOWN Tailgate Party Saturday, September 22 Claxton Education Building Corner of Andy Holt Ave and Volunteer Blvd UT vs. Akron 3 hours before kickoff ASP FALL PICNIC Wednesday, October 3 Memphis Forrest Park, 11 am-12 noon CT Knoxville Tyson Park, 11:30 am-1:30 pm ET INSIDE THIS ISSUE Faculty Students, Graduate Students & Residents Alumni & Friends Pages 2-9 Pages 9-13 Page 14
Transcript
TOP STORY
Meibohm President-Elect of
American College of Clinical Pharmacology
Bernd Meibohm, PhD, professor of Pharmaceutical Sciences and
associate dean for Research and Graduate Programs has been
elected as 2012-14 president-elect of the American College of
Clinical Pharmacology (ACCP).
His term will begin during the
ACCP Annual Meeting
September 23-25, 2012 in
San Diego. The president-
elect is part of the executive
committee and assumes the
duties of the president in
their absence. The president-
elect succeeds the president
once their two year term is
complete. “Regarding the
election, I am of course
honored by the trust and
confidence that the ACCP
Board of Regents has put in
me by electing me to this leadership role for the organization,”
said Meibohm. “The American College of Clinical Pharmacology
is truly an interprofessional organization in which pharmacists,
physicians and scientists are working jointly together to improve
drug development and applied pharmacotherapy. It overcomes
the usual silo structure of other professional organizations and
facilitates interactions among professionals as we all experience
them in our daily work and practice.”
September 2012
To serve as a model for pharmacy education, practice, research, and outreach in Tennessee and beyond
PHARMACY GRAND ROUNDS Thursday, September 20 Memphis COP Room 101, 12-1 pm CT Knoxville COP Room 220, 1-2 pm ET Drs. Rebecca Chhim and Andrea Franks
K-TOWN THROWDOWN Tailgate Party Saturday, September 22 Claxton Education Building Corner of Andy Holt Ave and Volunteer Blvd UT vs. Akron 3 hours before kickoff
ASP FALL PICNIC Wednesday, October 3 Memphis Forrest Park, 11 am-12 noon CT Knoxville Tyson Park, 11:30 am-1:30 pm ET
Dr. Meibohm received a BS in pharmacy and PhD in pharmaceutics from the Technical University of Carolo-
Wilhelmina in Braunschweig, Germany. After completion of a clinical pharmacology research fellowship at the
University of Florida in 1997, he joined the faculty of the University of South Carolina. In 1999, he joined the
University of Tennessee. Dr. Meibohm’s scientific interests include pulmonary infectious and inflammatory
diseases, pediatric pharmacotherapy and the application of quantitative modeling and simulation techniques in
preclinical and clinical drug development, with specific focus on therapeutic proteins. His research has attracted
more than $6 million in extramural funding as principal and co-investigator and has resulted in over 100 scientific
papers and book chapters, two textbooks, 130 abstracts, and over 100 invited scientific presentations to national
and international audiences.
Dr. Meibohm is a Fellow of the American Association of Pharmaceutical Scientists (AAPS) and American College of
Clinical Pharmacology (ACCP), and recipient of the 2000 AAPS ‘New Investigator Award in PK, PD and Drug
Metabolism.’ He chaired the 2010 ‘Pharmacokinetics, Pharmacodynamics and Drug Metabolism’ (PPDM) section
of AAPS and recently began a five year term on ACCP’s governing Board of Regents. Dr. Meibohm also serves as
associate editor for the AAPS Journal, as section editor for ‘Pharmacokinetics and Pharmacodynamics’ for the
Journal of Clinical Pharmacology, and is a member of the editorial boards for the Journal of Pediatric
Pharmacology and Therapeutics, the Journal of Pharmacokinetics and Pharmacodynamics, Les Annales
Pharmaceutiques Françaises and Die Pharmazie.
FACULTY
Academic Promotion and Tenure 2012
Michelle Farland, PharmD, BCPS, CDE was promoted to associate
professor of Clinical Pharmacy. Dr. Farland received a Doctor of Pharmacy
degree from the University of Pittsburgh School of Pharmacy in 2005. She
completed a pharmacy practice residency at Shands Jacksonville Medical
Center in Jacksonville, FL and a specialty residency in ambulatory
care/primary care at the Virginia Commonwealth University Medical
College of Virginia Hospitals in Richmond, VA. Dr. Farland joined the
faculty of the University of Tennessee Health Science Center College of
Pharmacy, Knoxville Campus in 2007. Her clinical practice is in an academic
primary care/internal medicine clinic. Her clinical research focuses on
pharmacist impact on patient outcomes for chronic disease states in
interdisciplinary care settings. She currently serves as the director of the University of Tennessee Pharmacist
Practice Based Research Network (UT Pharm Net). Dr. Farland has been a course director for two required courses
(Therapeutics 6 and Medication Therapy Management), and she directs an Ambulatory Care elective course. Dr.
Farland also serves as the campus advisor for Phi Lambda Sigma, who recognized her in 2011 as the Alumna of the
Year. She is also the 2012 recipient of the American College of Clinical Pharmacy New Educator award.
3 | P a g e
FACULTY
Promotion and Tenure – continued
Andrea S. Franks, PharmD, BCPS was tenured as an associate professor of
Clinical Pharmacy. She is also an associate professor of Family Medicine at
the University of Tennessee Graduate School of Medicine. Dr. Franks began
her faculty career with the College of Pharmacy in Memphis, and transferred
to East Tennessee to help establish the Knoxville campus in 2007. Her
clinical practice, teaching, and research site is in Family Medicine at the
University of Tennessee Medical Center (UTMC) in Knoxville. She
participates in college and campus committees and working groups
responsible for dual-campus educational programs and curriculum. In
addition to her clinical practice, Dr. Franks teaches throughout the PharmD
curriculum, and serves as a preceptor for UTMC pharmacy residency
programs. Dr. Franks has received several teaching awards including the UTHSC Student Government Association
Executive Council Excellence in Teaching Award (2007, 2012) and the University of Tennessee Alumni Association
Outstanding Teacher Award (2008). She has presented local, regional, and national presentations regarding
teaching and learning.
Amanda Howard-Thompson, PharmD, BCPS was promoted to associate professor of Clinical Pharmacy and Family
Medicine at the University of Tennessee Health Science Center. After graduating from the University of Tennessee
College of Pharmacy, Dr. Howard-Thompson completed a clinical
pharmacy residency in Pediatric Pharmacotherapy at LeBonheur Children’s
Medical Center and Internal Medicine at Methodist University Hospital in
Memphis, and then joined the faculty in 2007. Her clinical practice and
teaching site is the UT Family Practice Center in Memphis. Dr. Howard-
Thompson currently coordinates Self Care and Non-Prescription Drugs and
an Ambulatory Care elective course. In addition, she is an instructor in
Therapeutics I, V, and VI. Her practice and research interests include
general medicine, diabetes, tobacco cessation, asthma, anticoagulation,
and women’s health.
Michio Kurosu, PhD was tenured as an associate professor of
Pharmaceutical Sciences. Dr. Kurosu joined the faculty at Colorado State
University in 2006. There he held a joint appointment in the Department of Chemistry, and he was promoted to
associate professor 2009. Dr. Kurosu joined the University of Tennessee
College of Pharmacy as an associate professor in 2011. His laboratory is
known for the application of chemical principles to develop novel
chemotherapy for respiratory and lung diseases. He has studied bacterial
infections caused by Gram-positive bacteria including Mycobacterium
tuberculosis. He has a long-term interest in development of new antibacterial
agents targeting novel or unexploited drug targets. Dr. Kurosu has served on
a NIH peer reviewer committees as well as an ad hoc reviewer since 2009.
4 | P a g e
FACULTY
Promotion and Tenure – continued
Tao Lowe, PhD was tenured as an associate professor of Pharmaceutical Sciences. She is also an associate
professor of Biomedical Engineering at University of Tennessee Health Science Center. Previously, she was an
associate professor of Pharmaceutical Sciences at Thomas Jefferson University in Philadelphia, PA. Dr. Lowe was
also an assistant professor of Surgery, Bioengineering, and Materials Science and
Engineering, and co-director of the Integrated Graduate Degree Molecular
Toxicology Program at Pennsylvania State University. She received a PhD with an
Eximia Cum Laude from the University of Helsinki, Finland in 1998. She conducted
her two year postdoctoral research in the Chemical Engineering Department at
University of Wisconsin, Madison. Dr. Lowe has published more than two dozen
peer-reviewed papers on biomaterials, macromolecules, biomacromolecules, and
tissue engineering. She has given more than 130 presentations and more than 50
invited lectures. She has received funding support from the NIH, DOD, Coulter
Foundation, and Juvenile Diabetes Research Foundation.
McFarland ACCP Ambulatory Care PRN Chair-Elect
M. Shawn McFarland, PharmD, BCPS, BC-ADM is the new chair-elect for the American College of Clinical
Pharmacy (ACCP) Ambulatory Care PRN (practice research network). The ACCP Ambulatory Care PRN currently has
approximately 1400 members. The chair-elect oversees the operations of the PRN as a whole for the first year in
conjunction with the chair. Specifically, the chair-elect will be in charge of coordinating the PRN’s educational
session at the ACCP Annual Meeting. In addition, the chair-elect will
coordinate any additional educational activities during the year. The chair-
elect will then move into the chair position after one year. Dr. McFarland will
begin his term at the ACCP meeting this fall. “I am extremely excited to be the
incoming chair-elect for the Ambulatory Care PRN,” stated McFarland. “With
the implementation of the Patient Centered Medical Home Model,
ambulatory care pharmacists hold a unique opportunity to bring our expertise
in medication therapy management to the forefront of patient care. As one of
the largest PRNs, we look forward to championing that effort together within
the general membership of ACCP.”
Dr. McFarland is a native of Monteagle. He graduated from Middle Tennessee
State University with a Bachelor in Science in 1996. Dr. McFarland graduated
Magna Cum Laude from the University of Tennessee College of Pharmacy in
2000. He then completed an ambulatory care/community pharmacy
residency with the University of Tennessee in 2001. Dr. McFarland created the
anticoagulation clinic and diabetes care clinic at the Murfreesboro Medical Clinic and practiced at the clinic from
2001-2008. He now is a clinical pharmacy specialist in primary care at the Alvin C. York VA Medical Center in
Murfreesboro. He is an associate professor with the University of Tennessee College of Pharmacy and has
precepted hundreds of student pharmacists since graduation.
5 | P a g e
FACULTY
Wood Nominated for 2013 ACCP Regent Position
Dr. Chris Wood has been nominated for a 2013 American College of Clinical
Pharmacy (ACCP) Regent position. The ACCP Board of Regents consists of 11
elected members, five officers and six Regents. Four ACCP members are
nominated for Regent each year, of which two are elected for three year
terms. The Board of Regents is responsible for setting policies and procedures,
managing fiduciary issues, and developing and monitoring of the strategic
plan. Regents also serve as liaisons to committees and practice and research
networks (PRNs) and other duties as assigned by the President. Board of
Regents members are expected to provide leadership for ACCP's programs,
initiatives, policies, and mission. “I am fortunate to be nominated for Regent
this year,” said Wood. Dr. Wood is a 1996 graduate of the UT College of
Pharmacy. He completed a critical care residency and fellowship at UT, and has
been on faculty since 1999. He is currently an associate professor of Clinical
Pharmacy and a Board Certified Pharmacotherapy Specialist with Added
Qualifications in Infectious Diseases. Dr. Wood practices in trauma critical care at
the Regional Medical Center at Memphis and also serves as the residency program
director for the PGY2 critical care residency. He has been a member of ACCP since
1996 and was elected as a Fellow (FCCP) in 2007. He has also been an ACCP
committee member 8 times, a committee chair, and a Frontiers Fund captain
twice. Dr. Wood was elected as the president of the Mid-South College of Clinical
Pharmacy in 2004 and the chair of the Critical Care PRN in 2007.
Clinical Pharmacy Welcomes Leslie Hamilton
Leslie A. Hamilton, PharmD, BCPS, joined the University of Tennessee
College of Pharmacy as an assistant professor of Clinical Pharmacy on
the Knoxville Campus. She practices in neurology and critical care at
UT Medical Center. Prior to joining UT, Dr. Hamilton served on faculty
at Auburn University for three years and practiced in pulmonology and
critical care. Her interests are critical care, nutrition, and infectious
disease. Dr. Hamilton graduated with a BA in English Literature from
the University of Tennessee in 2003 and completed a Doctor of
Pharmacy at the University of Tennessee Health Science Center in
2007. She completed a PGY1 residency at Moses H. Cone Hospital in
Greensboro, NC, and a PGY2 residency in critical care/nutrition support
at the University of Tennessee/Regional Medical Center in Memphis.
Dr. Hamilton is originally from Oak Ridge and is glad to be back in the
area. She enjoys traveling and cooking in her spare time.
6 | P a g e
FACULTY
Haidar appointed to Board of Pharmacy Specialties Pediatrics Taskforce
Cyrine E. Haidar, BS Pharm, PharmD, BCPS, BCOP was recently appointed to the
Board of Pharmacy Specialties (BPS) Pediatrics Taskforce. The taskforce conducted
a study to help define the minimum expectations of a board certified practitioner
along with the knowledge, task and activities a pediatric pharmacist should be
able to complete. According to BPS Executive Director, William M. Ellis, “BPS
received almost 300 nominations to serve on the Pediatric Pharmacy and Critical
Care Pharmacy Practice Analysis Taskforces. The conduct of this and other role
delineation studies demonstrates the active commitment of BPS to recognize
pharmacy specialties and certify pharmacists' knowledge and skill at the advanced
practice level.” Dr. Haidar is a clinical pharmacy specialist in pediatric oncology at
St. Jude Children’s Research Hospital in Memphis and an assistant professor of
Clinical Pharmacy at the University of Tennessee College of Pharmacy. Dr. Haidar
received her BSPharm and PharmD degrees at the Lebanese American University
in Byblos, Lebanon. Following graduation, she completed a PGY1 residency at Hackensack University Medical
Center in Hackensack, New Jersey. This experience was followed in 2004-2005 by completion of a PGY-2 residency
in pediatric oncology at St Jude. She primarily practices in the ambulatory care setting with the Solid Tumor and
Neuro-Oncology teams and has precepted more than 40 student pharmacists and 10 pediatric oncology pharmacy
residents at St. Jude. Her main areas of interest are solid tumor malignancies, brain tumors and
pharmacogenetics. She assumes the position of clinical coordinator for Pharmacogenetics at St. Jude in
September 2012. Dr. Haidar has extensive experience in collaboration with professional societies, including
Hematology Oncology Pharmacists’ Association and Pediatric Pharmacy Advocacy Group.
Former HOPR Faculty Welcomed in Department of Clinical Pharmacy
As of July, all Health Outcomes and Policy (HOPR) faculty members were transitioned to the Department of Clinical
Pharmacy (DCP). Since HOPR and DCP faculty share common research interests, this move will offer opportunities
and open new doors for collaborative research. Although faculty have worked together on numerous occasions in
the past, they are excited and confident that the physical move of HOPR faculty into the DCP will facilitate more
effective collaborative research. The group of faculty members joining the DCP are Drs. Lawrence “L.B.” Brown,
Brandi Franklin, Song Hee Hong, Shelley White-Means, and Junling Wang.
Dr. Lawrence “LB” Brown is a tenured associate professor and director of
graduate studies in Health Outcomes and Policy Research. He completed his
Doctor of Pharmacy degree at the University of the Pacific and his PhD in Social
and Administrative Pharmacy at the University of Minnesota. His main research
interests are economic and clinical outcomes of pharmacists-provided
medication therapy management (MTM) services, and pharmacists’ expanded
patient care roles within the health care system.
7 | P a g e
FACULTY
HOPR Faculty Welcomed – continued
Dr. Brandi Franklin is an assistant professor and co-director and instructor for
the introductory HOPR policy course. Her primary areas of research include
diabetes burden in youth and adults, outcomes of disparate food access,
community and faith-based health promotion, and childhood obesity. “In terms
of the change to Clinical Pharmacy, I’m very excited about bringing HOPR’s
strengths in pharmacoeconomics, policy, and outcomes research to Clinical
Pharmacy,” stated Franklin. “We have great potential to embark on translational
research through collaboration.”
Dr. Song Hong is an associate professor and faculty member for the graduate
program in Health Outcomes and Policy Research. He obtained a PhD in
pharmacy administration from University of Texas at Austin and MA in
economics from Virginia Commonwealth University. His research interests are
in outcome evaluation of pharmaceutical products and services, pharmaco-
epidemiology, pharmacy benefit designs and drug pricing. “As DCP increasingly
emphasizes translational clinical practice for innovative clinical services and
practice models, there seem ample opportunities [for collaboration]” Hong said.
Dr. Junling Wang is an associate professor and received a PhD in Pharmaceutical
Health Services Research from the University of Maryland in 2005 focusing on the
application of quantitative analysis in outcomes research and
pharmacoeconomics. “I am very excited about HOPR faculty members moving to
the DCP. The research interests of HOPR faculty members are very well aligned
with faculty colleagues at the DCP and this move will better facilitate the
collaboration between HOPR faculty and other DCP faculty members,” explained
Wang.
Dr. Shelley White-Means is a professor of Pharmaceutical Sciences and executive
director of Consortium on Health Education, Economic Empowerment and
Research (CHEER). Her research specialty and focus are in health disparities,
economics of aging, the cost of caregiving, economics, minority health and health
care utilization.
8 | P a g e
FACULTY PUBLICATIONS
Boucher BA, Wood GC. Role of amantadine in promoting functional recovery in patients following severe traumatic brain injury. (Update). In: Talbert RL, DiPiro JT, Matzke GR, Posey LM, Wells BG, Yee GC, eds. Pharmacotherapy: A Pathophysiologic Approach. 8th ed. New York: McGraw-Hill; 2012. http://www.accesspharmacy.com/updatescontent.aspx?aid=4000155. Accessed August 27, 2012. Martin SJ, Micek ST, Wood GC. Antimicrobial resistance is an adverse drug event. In: Papadopoulos J, Cooper B, Kane-Gill S, Corbett SM, Barletta J, eds. Drug-Induced Complications in the Critically Ill Patient: A Guide for Recognition and Treatment. 1st ed. Mt. Prospect, IL: Society of Critical Care Medicine; 2012:1-12. Kelmer G, Bell GC, Martin-Jimenez T, Saxton AM, Catasus C, Elliot SB, Meibohm B. Evaluation of regional limb perfusion with amikacin using the saphenous, cephalic and palmar digital veins in standing horses. Journal of Veterinary Pharmacology and Therapeutics 2012, May 18 [Epub ahead of print]. Barrett JS, Della Casa Alberighi O, Laer S, Meibohm B. Physiologically-based pharmacokinetic (PBPK) modeling in children. Clinical Pharmacology and Therapeutics 2012, 92, 40-9. Aldrich MC, Kumar R, Colangelo LA, Williams LK, Sen S, Kritchevsky SB, Meibohm B, Galanter J, Hu D, Gignoux CR, Liu Y, Harris TB, Ziv E, Zmuda J, Garcia M, Leak TS, Foreman MG, Smith LJ, Fornage M, Liu K, Burchard EG; for the Health ABC and CARDIA Studies. Genetic ancestry-smoking interactions and lung function in African Americans: A cohort study. PLoS One 2012, 7(6), e39541. van den Borst B, Gosker HR, Koster A, Yu B, Kritchevsky SB, Liu Y, Meibohm B, Rice TB, Shlipak M, Yende S, Harris TB, Schols AM; for the Health Aging, and Body Composition (Health ABC) Study. The influence of abdominal visceral fat on inflammatory pathways and mortality risk in obstructive lung disease. American Journal of Clinical Nutrition 2012, 96(3), 516-26. Wilk JB, Shrine NR, Loehr LR, Zhao JH, Manichaikul A, Lopez LM, Smith AV, Heckbert SR, Smolonska J, Tang W, Loth DW, Curjuric I, Hui J, Cho MH, Latourelle JC, Henry AP, Aldrich M, Bakke P, Beaty TH, Bentley AR, Borecki IB, Brusselle GG, Burkart KM, Chen TH, Couper D, Crapo JD, Davies G, Dupuis J, Franceschini N, Gulsvik A, Hancock DB, Harris TB, Hofman A, Imboden M, James AL, Khaw KT, Lahousse L, Launer LJ, Litonjua A, Liu Y, Lohman KK, Lomas DA, Lumley T, Marciante KD, McArdle WL, Meibohm B, Morrison AC, Musk AW, Myers RH, North KE, Postma DS, Psaty BM, Rich SS, Rivadeneira F, Rochat T, Rotter JI, Soler Artigas M, Starr JM, Uitterlinden AG, Wareham NJ, Wijmenga C, Zanen P, Province MA, Silverman EK, Deary IJ, Palmer LJ, Cassano PA, Gudnason V, Barr RG, Loos RJ, Strachan DP, London SJ, Boezen HM, Probst-Hensch N, Gharib SA, Hall IP, O'Connor GT, Tobin MD, Stricker BH. Genome wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction. American Journal of Respiratory and Critical Care Medicine 2012, Jul 26 [Epub ahead of print]. Lee DSH, DeRekeniere N, Hanlon JT, Gill TM, Bauer DC, Meibohm B, Harris TB, Jeffrey SM. Cognitive impairment and medication complexity in community-living older adults: The Health, Aging and Body Composition Study. Journal of Pharmacy Technology 2012, 28, 156-62. Swanson JM, Wood GC, Xu L, Tang LE, Meibohm B, Homayouni R, Croce MA, Fabian TC. Developing a gene expression model for predicting ventilator-associated pneumonia in trauma patients: A pilot study. PLoS One 2012;7:e42065.
